• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BD1
Click for more information
1.63% $3.11

BARD1 LIFE SCIENCES LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

BARD1 Life Sciences Ltd is an Australia-based life sciences company. The Company is... BARD1 Life Sciences Ltd is an Australia-based life sciences company. The Company is engaged in developing diagnostics and therapeutics for unmet needs in cancer. Its proprietary BARD1 Technology is based on BARD1, a potent tumour suppressor in healthy individuals and important tumour biomarker in cancer. Its lead product the BARD1 Lung Cancer Test is a non-invasive blood test in development for early detection of lung cancer. It is also engaged in researching a pipeline of potential diagnostic and therapeutic products for multiple cancers. The Company’s pipeline also includes BARD1 Ovarian Cancer Test and BARD1 Ribonucleic Acid (RNA) Test.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BD1 Notice of Annual General Meeting/Proxy Form-BD1.AX 07/10/16
BD1 Statutory Audited Financial Statements-BD1.AX 30/09/16
BD1 Company Update - Promising Result for Ovarian Cancer-BD1.AX PRICE SENSITIVE22/09/16
BD1 Preliminary Final Report - Appendix 4E-BD1.AX PRICE SENSITIVE31/08/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 04/08/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 02/08/16
BD1 Quarterly Activities Report and Appendix 4C-BD1.AX PRICE SENSITIVE28/07/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 12/07/16
BD1 Becoming a Substantial Holder - Walker-BD1.AX 12/07/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 06/07/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 30/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 28/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 21/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX 20/06/16
BD1 Becoming a substantial holder-BD1.AX 20/06/16
BD1 Notice of Annual General Meeting/Proxy Form-BD1.AX
07/10/16
BD1 Statutory Audited Financial Statements-BD1.AX
30/09/16
BD1 Company Update - Promising Result for Ovarian Cancer-BD1.AX
22/09/16PRICE SENSITIVE
BD1 Preliminary Final Report - Appendix 4E-BD1.AX
31/08/16PRICE SENSITIVE
BD1 Appendix 3Y - Gunzburg-BD1.AX
04/08/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
02/08/16
BD1 Quarterly Activities Report and Appendix 4C-BD1.AX
28/07/16PRICE SENSITIVE
BD1 Appendix 3Y - Gunzburg-BD1.AX
12/07/16
BD1 Becoming a Substantial Holder - Walker-BD1.AX
12/07/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
06/07/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
30/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
28/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
21/06/16
BD1 Appendix 3Y - Gunzburg-BD1.AX
20/06/16
BD1 Becoming a substantial holder-BD1.AX
20/06/16
refresh Created with Sketch. REFRESH
 

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.